These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 21399606

  • 1. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M, Eskandari M, Kharazizadeh M, Khamesipour A, Jaafari MR.
    Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606
    [Abstract] [Full Text] [Related]

  • 2. Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN.
    Tafaghodi M, Khamesipour A, Jaafari MR.
    Parasitol Res; 2011 May; 108(5):1265-73. PubMed ID: 21125294
    [Abstract] [Full Text] [Related]

  • 3. Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis.
    Tafaghodi M, Eskandari M, Khamesipour A, Jaafari MR.
    Exp Parasitol; 2011 Oct; 129(2):107-14. PubMed ID: 21767536
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit.
    Mohaghegh M, Tafaghodi M.
    Pharm Dev Technol; 2011 Feb; 16(1):36-43. PubMed ID: 20082579
    [Abstract] [Full Text] [Related]

  • 6. Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB/c mice.
    Soudi S, Hosseini AZ, Hashemi SM.
    Parasite Immunol; 2011 Oct; 33(10):561-71. PubMed ID: 21781137
    [Abstract] [Full Text] [Related]

  • 7. Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis.
    Shargh VH, Jaafari MR, Khamesipour A, Jaafari I, Jalali SA, Abbasi A, Badiee A.
    Vaccine; 2012 Jun 06; 30(26):3957-64. PubMed ID: 22465747
    [Abstract] [Full Text] [Related]

  • 8. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
    Ferreira JH, Gentil LG, Dias SS, Fedeli CE, Katz S, Barbiéri CL.
    Vaccine; 2008 Jan 30; 26(5):677-85. PubMed ID: 18160187
    [Abstract] [Full Text] [Related]

  • 9. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
    Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Exp Parasitol; 2009 Apr 30; 121(4):362-9. PubMed ID: 19211022
    [Abstract] [Full Text] [Related]

  • 10. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E, Casas CP, Borja-Cabrera GP, Santos FN, Nico D, Souza LO, Tinoco LW, da Silva BP, Palatnik M, Parente JP, Palatnik-de-Sousa CB.
    Vaccine; 2006 May 01; 24(18):3909-20. PubMed ID: 16556475
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis.
    Heravi Shargh V, Jaafari MR, Khamesipour A, Jalali SA, Firouzmand H, Abbasi A, Badiee A.
    Parasitol Res; 2012 Jul 01; 111(1):105-14. PubMed ID: 22223037
    [Abstract] [Full Text] [Related]

  • 13. Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis.
    Nagill R, Kaur S.
    Vaccine; 2010 May 21; 28(23):4002-12. PubMed ID: 20093205
    [Abstract] [Full Text] [Related]

  • 14. Early immune responses in Atlantic salmon (Salmo salar L.) after immunization with PLGA nanoparticles loaded with a model antigen and β-glucan.
    Fredriksen BN, Sævareid K, McAuley L, Lane ME, Bøgwald J, Dalmo RA.
    Vaccine; 2011 Oct 26; 29(46):8338-49. PubMed ID: 21888940
    [Abstract] [Full Text] [Related]

  • 15. The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome.
    Jaafari MR, Badiee A, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Vaccine; 2007 Aug 10; 25(32):6107-17. PubMed ID: 17629372
    [Abstract] [Full Text] [Related]

  • 16. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B, Irache JM, Gómez S, Tsapis N, Gamazo C, Espuelas MS.
    Eur J Pharm Biopharm; 2008 Sep 10; 70(1):98-108. PubMed ID: 18501572
    [Abstract] [Full Text] [Related]

  • 17. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D, Molavi O, Lutsiak ME, Elamanchili P, Kwon GS, Samuel J.
    J Pharm Pharm Sci; 2007 Sep 10; 10(2):217-30. PubMed ID: 17706180
    [Abstract] [Full Text] [Related]

  • 18. Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection.
    Daifalla NS, Bayih AG, Gedamu L.
    Exp Parasitol; 2012 Jul 10; 131(3):317-24. PubMed ID: 22580023
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.
    Margaroni M, Agallou M, Athanasiou E, Kammona O, Kiparissides C, Gaitanaki C, Karagouni E.
    Int J Nanomedicine; 2017 Jul 10; 12():6169-6184. PubMed ID: 28883727
    [Abstract] [Full Text] [Related]

  • 20. PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice.
    Ribeiro S, Rijpkema SG, Durrani Z, Florence AT.
    Int J Pharm; 2007 Mar 01; 331(2):228-32. PubMed ID: 17258876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.